Maria Hatara, MD
Gastroenterology · Huntersville, NCNPI 1427217439
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.9% of the total across 292 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 30 manufacturers reported payments, led by AbbVie at 26.3% of the total. Reporting peaked in 2021 at $1,778 and has fallen 80.9% since, to $340 in 2025.
Across 292 payments — averaging $21.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$617
- Gilead$512
- Bristol Myers Squibb$503
- E.r. Squibb & Sons, L.L.C.$475
- Takeda Pharmaceuticals U.S.A., Inc.$364
- plus $2K from 24 others
Across 3 payments — averaging $653.55 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eli Lilly$2K
What the payments were for
- Food & beverage$6,150100%
- Education$70%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 81 | $1,622 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 39 | $617 |
| Gilead | 21 | $512 |
| Bristol Myers Squibb | 37 | $503 |
| E.r. Squibb & Sons, L.L.C. | 4 | $475 |
| Takeda Pharmaceuticals U.S.A., Inc. | 18 | $364 |
| Johnson & Johnson | 16 | $281 |
| Medtronic | 2 | $203 |
| Ferring Pharmaceuticals Inc. | 8 | $176 |
| Intercept Pharmaceuticals, Inc. | 10 | $164 |
| Enterra Medical, Inc. | 1 | $145 |
| QOL Medical, LLC | 8 | $144 |
| Pfizer | 7 | $133 |
| Regeneron Healthcare Solutions, Inc. | 4 | $124 |
| Cumberland Pharmaceuticals, Inc. | 6 | $109 |
| Braintree Laboratories, Inc. | 5 | $84 |
| Nestle Healthcare Nutrition Inc. | 5 | $75 |
| Ironwood Pharmaceuticals, Inc | 4 | $74 |
| Janssen Scientific Affairs, LLC | 1 | $61 |
| Pentax Of America, Inc. | 2 | $59 |
| Alnylam Pharmaceuticals Inc. | 2 | $37 |
| Redhill Biopharma Inc. | 2 | $35 |
| Merck | 2 | $33 |
| Amgen | 1 | $23 |
| Phathom Pharmaceuticals, Inc. | 1 | $21 |
| AstraZeneca | 1 | $21 |
| Shionogi Inc | 1 | $17 |
| Vivus LLC | 1 | $17 |
| Romark Laboratories, LC | 1 | $15 |
| Boston Scientific | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,157 in reported general payments places this provider in the 70th percentile of 610 gastroenterology providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates | 27 | $1,757 |
| Omeprazole | 96 | $1,034 |
| Pantoprazole Sodium | 14 | $87 |
Paid to pharmacies, not to this prescriber.
Other gastroenterology in Huntersville
- Stephen DealCharlotte$945K
- Fred FowlerCharlotte$932K
- Paul WatkinsChapel Hill$876K
- Nilesh LodhiaCharlotte$735K
- Evan DellonChapel Hill$431K
- Robert ReindollarSalisbury$430K
- Andrew StormWinston Salem$426K
- John PoulosFayetteville$407K
- Manal AbdelmalekDurham$402K
- Christopher McGowanCary$223K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.